Troy A. Markel

Dr. Troy A. Markel

Indiana University School of Medicine, Indianapolis, IN, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Cytokine
Verified
Journal Article
Closed access
TCTrevor D. Crafts
Trevor D. Crafts
AJAmanda R. Jensen
Amanda R. Jensen
EBEthan C. Blocher-Smith
Ethan C. Blocher-Smith
TMTroy A. Markel
Troy A. Markel

1 November 2017 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
TMTroy A. Markel
Troy A. Markel
TGThomas Gormley
Thomas Gormley
DGDamon Greeley
Damon Greeley
JOJohn Ostojic
John Ostojic
AWAngie Wise
Angie Wise
JWJennifer Wagner
Jennifer Wagner
The effectiveness of operating room headgear in preventing airborne contamination has been called into question. We hypothesized that bouffant style hats would be as effective in preventing bacterial and particulate contamination in the operating room compared with disposable or cloth skull caps, and bouffant style hats would have similar permeability, particle penetration, and porosity compared with skull caps. Disposable bouffant and skull cap hats and newly laundered cloth skull caps were tested. A mock surgical procedure was used in a dynamic operating room environment. Airborne particulate and microbial contaminants were sampled. Hat fabric was tested for permeability, particle transmission, and pore sizes. No significant differences were observed between disposable bouffant and disposable skull caps with regard to particle or actively sampled microbial contamination. However, when compared with disposable skull caps, disposable bouffant hats did have significantly higher microbial shed at the sterile field, as measured by passive settle plate analysis (p < 0.05). When compared with cloth skull caps, disposable bouffants yielded higher levels of 0.5 μm and 1.0 μm particles and significantly higher microbial shed detected with passive analysis. Fabric assessment determined that disposable bouffant hats had larger average and maximum pore sizes compared with cloth skull caps, and were significantly more permeable than either disposable or cloth skull caps. Disposable bouffant hats had greater permeability, penetration, and greater microbial shed, as assessed by passive microbial analysis compared with disposable skull caps. When compared with cloth skull caps, disposable bouffants yielded greater permeability, greater particulate contamination, and greater passive microbial shed. Disposable style bouffant hats should not be considered superior to skull caps in preventing airborne contamination in the operating room.

1 February 2018 in Seminars in Pediatric Surgery
Verified
Journal Article
Open access
NDNatalie A. Drucker
Natalie A. Drucker
CMChristopher J. McCulloh
Christopher J. McCulloh
BLBo Li
Bo Li
APAgostino Pierro
Agostino Pierro
GBGail E. Besner
Gail E. Besner
TMTroy A. Markel
Troy A. Markel
Stem cell therapy is a promising treatment modality for necrotizing enterocolitis. Among the many promising stem cells identified to date, it is likely that mesenchymal stem cells will be the most useful and practical cell-based therapies for this condition. Using acellular components such as exosomes or other paracrine mediators are promising as well. Multiple mechanisms are likely at play in the positive effects provided by these cells, and further research is underway to further elucidate these effects.

1 January 2014 in Journal of Clinical Neonatology
Verified
Journal Article
Open access
TMTroy A. Markel
Troy A. Markel
HEHolly Engelstad
Holly Engelstad
BPBrendaB Poindexter
BrendaB Poindexter
Necrotizing enterocolitis (NEC) remains a very devastating problem within the very low birth weight neonatal population. Several experimental therapies are being tested in animal models and soon may be ready for human trials. Despite this progress, we currently have no way to identify infants who would be optimal targets for therapy. Specifically, we are unable to predict which infants will progress to the more severe Bell's stage of disease that may necessitate surgery. Ideally, an algorithm could be constructed that would encompass multiple neonatal and maternal risk factors as well as potential biologic markers of disease so that these infants could be identified in a more timely fashion. This review summarizes the known risk factors and biomarkers of disease in hopes of stimulating clinical research to identify such an "early warning" NEC algorithm.

1 November 2008 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
TMTroy A. Markel
Troy A. Markel
PCPaul R. Crisostomo
Paul R. Crisostomo
TLTim Lahm
Tim Lahm
NNNathan M. Novotny
Nathan M. Novotny
FRFrederick J. Rescorla
Frederick J. Rescorla
DMDaniel R. Meldrum
Daniel R. Meldrum

10 September 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
JLJianyun Liu
Jianyun Liu
FMFikir M. Mesfin
Fikir M. Mesfin
CHChelsea E. Hunter
Chelsea E. Hunter
Kenneth OlsonKenneth Olson
Kenneth Olson
CSChris Shelley
Chris Shelley
TMTroy A. Markel
Troy A. Markel
Hydrogen sulfide has been recently identified as the third biological gasotransmitter, along with the more well studied nitric oxide (NO) and carbon monoxide (CO). Intensive studies on its potential as a therapeutic agent for cardiovascular, inflammatory, infectious and neuropathological diseases have been undertaken. Here we review the possible direct targets of H2S in mammals. H2S directly interacts with reactive oxygen/nitrogen species and is involved in redox signaling. H2S also reacts with hemeproteins and modulates metal-containing complexes. Once being oxidized, H2S can persulfidate proteins by adding -SSH to the amino acid cysteine. These direct modifications by H2S have significant impact on cell structure and many cellular functions, such as tight junctions, autophagy, apoptosis, vesicle trafficking, cell signaling, epigenetics and inflammasomes. Therefore, we conclude that H2S is involved in many important cellular and physiological processes. Compounds that donate H2S to biological systems can be developed as therapeutics for different diseases.